180 Life Sciences Corp.
ATNF
Revenue
0.00
0.000.00%
-Assets
3.91M
▲469.71k▲13.65%
3 Months ChangeLiabilities
4.33M
▼-66.77k▼-1.52%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001213900-24-092501
2024-10-29
Form 8-K
ID: 0001213900-24-091732
2024-10-29
Form 8-K
ID: 0001213900-24-091422
2024-10-21
Form 8-K
ID: 0001213900-24-089354
2024-10-16
Form 8-K
ID: 0001213900-24-088119
2024-10-16
Form 8-K
ID: 0001213900-24-087976
2024-10-09
Form 8-K
ID: 0001213900-24-086401
2024-10-03
Form 8-K
ID: 0001213900-24-084859
2024-09-12
Form 8-K
ID: 0001213900-24-078158
2024-09-09
Form 8-K
ID: 0001213900-24-076949